View up-to-date information on Cytodyn Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4007603A1 | Application | VERFAHREN ZUR BEHANDLUNG ODER VORBEUGUNG VON KREBS DURCH VERABREICHUNG VON ANTI-CCR5-REZEPTORMITTELN | A61K2039/505; A61P35/04; C07K16/2866; C07K2317/24; C07K2317/76 | June 08, 2022 |
BR112022001037A2 | Application | Métodos para tratamento ou prevenção de cânceres envolvendo a administração de agentes receptores anti-ccr5 | A61K2039/505; A61P35/04; C07K16/2866; C07K2317/24; C07K2317/76 | June 07, 2022 |
US20220162327A1 | Application | ANTI-CCR5 AGENTS AND METHODS OF TREATMENT THAT BLOCK CANCER METASTASIS OR ENHANCE CELL DEATH INDUCED BY DNA DAMAGING CHEMOTHERAPY | A61K2039/545; A61K31/704; A61P35/00; C07K16/2866 | May 26, 2022 |
AU2022201992A1 | Application | Using modulators of CCR5 for treating cancer | A61K31/4184; A61K31/4375; A61K31/46; A61K31/506; A61P35/00; A61P35/02; A61P35/04; C12Q1/6886; C12Q2600/118; C12Q2600/158; G01N2333/705; G01N2333/7158; G01N2800/56; G01N33/5091; G01N33/57415; G01N33/57484; G01N33/57492 | April 14, 2022 |
AU2020324948A1 | Application | Methods for treating or preventing cancers involving the administration of anti-CCR5 receptor agents | A61K2039/505; A61P35/04; C07K16/2866; C07K2317/24; C07K2317/76 | February 17, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer